| 摘要 |
The invention relates to a pharmaceutical composition for treating pathological effects induced by the muscle relaxant succinylcholine in its therapeutic administration forms, such as hyperactivity of creatine kinase, hypermyoglobinaemia and fasciculations, which contains 1-[[5-(p-nitrophenyl)furfurylidene]amino]hydantoin as active ingredient.
|
